For more details on the courses, please refer to the Course Catalog
| Code | Course Title | Credit | Learning Time | Division | Degree | Grade | Note | Language | Availability |
|---|---|---|---|---|---|---|---|---|---|
| IPS5061 | Pharmaceutical Industry Project Research | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | Korean | Yes | |
| This course is designed for students who want to replace master's thesis. Students will learn research topic selection and research methodology. Students will be able to research, arrange, This is an individual research subject in which the supervisor evaluates the results of the research. | |||||||||
| IPS5062 | Seminars in social pharmacy and public health | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | Korean | Yes | |
| This course will focuse on lectures seminars, and discussion by students. The class will include policy study, economic evaluation, and epidemiological study. | |||||||||
| IPS5063 | Healthcare big data analysis and programming | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | Korean,Korean | Yes | |
| This course will focus on big data analysis using nationwide health insurance database. The example will include SAS program coding, and diverse case studies. | |||||||||
| IPS5064 | Drug pricing and reimbursement strategy practice | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | Korean | Yes | |
| This course consists of practicing and discussing the listing for reimbursement and drug price strategy, allowing the students to perform their jobs immediately after graduation. According to the characteristics of diseases and drugs, students are going to prepare the dossier for listing on the pharmaceutical list of new drugs that have been approved for marketing. | |||||||||
| IPS5065 | Systematic review and meta-analysis | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | - | No | |
| This course intend to understand systematic review and meta-analysis as a methodology of evidence-based pharmacy. It will cover the basic theory and application. | |||||||||
| IPS5067 | Bio-Entrepreneurship Capstone Design | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | - | No | |
| This course aims to select actual problems encountered in corporate business activities of bio-venture companies and pharmaceutical companies, and to derive solutions for problems. Starting from the definition of the problem, the process of analyzing various pending issues for the problem, designing an alternative through it, and establishing an action stratey for the alternative is included. Various techniques such as data research, expert research, and brainstorming are used to carry out the process. | |||||||||
| IPS5068 | Pharmaco-Data Science Capstone Design | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | - | No | |
| This course aims to derive solutions to real problems encountered by pharmaceutical companies in relation to the use of real world data in the areas of drug research and development and pharmacovigilance. To this end, the process starts with the setting and definition of the problem, analyzes various pending isstues for the problem, designs alternatives through this, and establishes an action strategy for the alternative. | |||||||||
| IPS5069 | Pharmaceutical Regulatory Affairs Capstone Design | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | - | No | |
| This course aims to select actual problems encountered by pharmaceutical companies in the process of drug approval and to derive solutions to those problems. To this end, starting with the definition of the problem, the current state is diagnosed and various pending issues are anlayzed. This process includes designing alternatives and establishing implementation strategies for the alternatives. | |||||||||
| IPS5070 | Pharmaceutical Market Access Capstone Design | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | Korean | Yes | |
| This course aims to identify actual problems encountered by pharmaceutical companies in the process of accessing market, such as insurance coverage and drug price determination, and to derive solutions to those problems. To this end, the process starts with the definition of the problem, analyzes various pending issues for the problem, designs alternatives through it, and establishes an action strategy for the alternative. | |||||||||
| IPS5071 | Basic pharmaco-statistics | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | Korean | Yes | |
| This course intend to understand basic concept of statistic in pharmaco-data science. Lecture will include concept of probability distribution, descriptive and inferential statistics. It will also cover t-test, chi-square test, ANOVA as well as correlation/regression, and survival analysis. | |||||||||
| IPS5072 | Econometrics and Pharmaceuticals | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | - | No | |
| The goal of this lecture is to understand econometric analysis methods to find the causal relationships between the variables that have impact on the pharmaceutical policies. This course will cover the basic theory of regression analysis, structural models for panel data and instrumental variables. Students will be able to analyze pharmaceutical policies using the health insurance claims data based on econometric methods. | |||||||||
| IPS5073 | Decision Analytic Modeling for Economic Evaluation | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | English | Yes | |
| This course will cover the theoretical and practical analytical methods so that economics evaluation of medicines can be actually carried out. To do this, students will learn modeling methods such as decision analysis, Markov modeling, and partitioned survival models. In addition, methods for comparative effectiveness will be introduced such as meta-analysis and indirect comparison using clinical trial study results. Also discuss the merits and limitations of the methodologies of economic evaluation. | |||||||||
| IPS5074 | Health Economics and Pharmaceuticals | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | Korean | Yes | |
| This course is designed to help student understand the basic theories and methods of economics, and apply them to health care services. Students will acquire knowledge about the socio-economic characteristics of health care, the roles of the nation, and the determinants of demand and supply of health care services. In addition major policy issues such as optimizing drug expenditure, economic evaluation of new drugs and medicines services, pharmacists' supply and demand, and long-term prospects of pharmaceutical services in the fourth industrial revolution era are to be discussed based on the economic theory and analysis methodologies. | |||||||||
| IPS5075 | Strategic Management of Pharmaceutical Innovation | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | Korean | Yes | |
| This course deals with strategic management issues in technology innovation of pharmaceutical companies based on the strategic management and innovation theory. This course covers key issues in strategic management including strategic alliances and international management, and key factors that affect the performance and productivity of new drug development such as time, probability, cost, and open innovation strategy. | |||||||||
| IPS5076 | Seminars in Social Pharmacy 1 | 3 | 6 | Major | Master/Doctor | Industrial Pharmaceutical Science | - | No | |
| This class will be a seminar with a presentation and discussion by student. Selected publications will be recent drug policy study, economic evaluation, and pharmacoepidemiological research. This class will include a journal presentation, a group discussion, and protocol presentation. | |||||||||